2025-04-08 19:34:47
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Gufic Biosciences Ltd posts net profit of Rs. 23.33 crore in Q2FY22
Posted On : 2021-11-06 21:29:23( TIMEZONE : IST )
Gufic Biosciences Limited has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 194.4444 crores during the period ended September 30, 2021 as compared to Rs. 251.9859 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 23.3362 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 31.2070 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 2.41 for the period ended September 30, 2021 as compared to Rs. 3.22 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 194.4444 crs | ₹251.9859 crs |  -22.84% |
| Net Profit | ₹23.3362 crs | ₹31.2070 crs | -25.22% |
| EPS | ₹2.41 | ₹3.22 | -25.16% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 194.4444 crores during the period ended September 30, 2021 as compared to Rs.130.6797 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.23.3362 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.17.3295 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.2.41 for the period ended September 30, 2021 as compared to Rs.1.79 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 194.4444 crs | ₹130.6797 crs |  48.79% |
| Net Profit | ₹23.3362 crs | ₹17.3295 crs | 34.66% |
| EPS | ₹2.41 | ₹1.79 | 34.64% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.446.4303 crores during the 6 Months period ended September 30, 2021 as compared to Rs.192.2568 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.54.5432 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.15.8963 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.5.63 for the 6 Months period ended September 30, 2021 as compared to Rs.1.64 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹446.4303 crs | ₹192.2568 crs | 132.21% |
| Net Profit | ₹54.5432 crs | ₹15.8963 crs | 243.12% |
| EPS | ₹5.63 | ₹1.64 | 243.29% |
Shares of Gufic Biosciences Limited was last trading in BSE at Rs. 187.65 as compared to the previous close of Rs. 193.90. The total number of shares traded during the day was 25196 in over 757 trades.
The stock hit an intraday high of Rs. 189.70 and intraday low of 184.25. The net turnover during the day was Rs. 4715129.00.
